Concepedia

S. Grolnic

SG

Statistics

Publications

3

Citations

62

H-Index

3

Active since

2007

Affiliations

University of Colorado Denver(Current)

University of Colorado Cancer Center

S. Grolnic is an author at University of Colorado Denver specializing in chemotherapy, pharmacodynamics of anticancer agents, and pharmacodynamics of anticancer drugs.

Publications per year

2007–2011

3

Publications

3

A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors

Laura Q.M. Chow, Sabine Eckhardt, Cindy L. O’Bryant et al. · Cancer Chemotherapy and Pharmacology · 2007 · 25 citations · Full text

, , +10

A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies

Laura Q.M. Chow, Daniel L. Gustafson, Cindy L. O’Bryant et al. · Cancer Chemotherapy and Pharmacology · 2008 · 25 citations · Full text

, , +7

Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies

Lia Gore, E. Rivera, M. Basche et al. · Investigational New Drugs · 2011 · 12 citations

, , +9

1–3 of 3